🇨🇦 Besifloxacin 0.6% ophthalmic suspension in Canada

Besifloxacin 0.6% ophthalmic suspension (Besifloxacin 0.6% ophthalmic suspension) regulatory status in Canada.

Marketing authorisation

Besifloxacin 0.6% ophthalmic suspension in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Besifloxacin 0.6% ophthalmic suspension approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Besifloxacin 0.6% ophthalmic suspension in Canada?

Johns Hopkins University is the originator. The local marketing authorisation holder may differ — check the official source linked above.